Home › Calculator › BIXT Dividend Calculator 2026
BIXT Dividend DRIP Calculator 2026
8368.20% YieldHealthcareBioxytran, Inc. · OTC
Price: $0.02 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BIXT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BIXT snowball 📈
$10,000 in BIXT → $189631942825405504.00M in 10 years · $15,616,050,103,381,712,000,000.00/month
About Bioxytran, Inc. (BIXT) — Dividend Analysis 2026
Bioxytran, Inc. is a pharmaceutical firm operating in the clinical development phase, dedicated to creating, producing, and marketing medicinal treatments for oxygen deficiency (hypoxia) in people. Its primary drug under development, BXT-25, is a small, oxygen-transporting molecule crafted from bovine hemoglobin, stabilized by a co-polymer. This compound is intended for tackling oxygen deprivation in the brain caused by strokes, as well as addressing wound hypoxia to avert tissue death and encourage recovery. Additionally, Bioxytran is advancing ProLectin-Rx, a pectin-derived polysaccharide. This substance functions by attaching to and inhibiting galectin-1, a specific galectin, to treat mild to moderate instances of Covid-19. Established in 2008, the company maintains its main office in Newton, Massachusetts.
Compare BIXT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BIXT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BIXT position with:
🌍 BIXT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BIXT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 8368.20% | 8365.40% | $836,820 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 7112.97% | 7110.17% | $711,297 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 6694.56% | 6691.76% | $669,456 / yr |
| 🇬🇧 UK ISA | 0% | 8368.20% | 8365.40% | $836,820 / yr |
| 🇬🇧 UK Taxable | 8.75% | 7635.98% | 7633.18% | $763,598 / yr |
| 🇨🇦 TFSA | 0% | 8368.20% | 8365.40% | $836,820 / yr |
| 🇨🇦 CA Taxable | 25% | 6276.15% | 6273.35% | $627,615 / yr |
| 🇦🇺 Super (pension) | 15% | 7112.97% | 7110.17% | $711,297 / yr |
| 🇦🇺 AU Taxable | 30% | 5857.74% | 5854.94% | $585,774 / yr |
| 🇩🇪 DE Taxable | 26.375% | 6161.09% | 6158.29% | $616,109 / yr |
| 🇫🇷 FR Taxable | 30% | 5857.74% | 5854.94% | $585,774 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BIXT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BIXT Dividend Payment Schedule
BIXT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 BIXT vs Healthcare Benchmarks
How BIXT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BIXT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BIXT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-11-14 | 38,588 | $0.35 | $13.5K | ||
| A-Award | 2025-08-12 | 10,417 | $0.48 | $5.1K | ||
| Buy | 2025-11-18 | 210,000 | $0.60 | $126.0K | ||
| A-Award | 2025-11-14 | 38,588 | $0.35 | $13.5K | ||
| A-Award | 2025-08-12 | 10,417 | $0.48 | $5.1K | ||
| A-Award | 2025-11-14 | 38,588 | $0.35 | $13.5K | ||
| A-Award | 2025-08-12 | 10,417 | $0.48 | $5.1K | ||
| A-Award | 2025-11-14 | 38,588 | $0.35 | $13.5K | ||
| J-Other | 2024-10-24 | 11,433,448 | $0.55 | $6.23M | ||
| J-Other | 2024-10-24 | 14,085,410 | $0.28 | $4.01M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BIXT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Bioxytran, Inc. (BIXT) is currently trading at $0.02, 98% below its 52-week high. The current dividend yield is 8368.20% based on an annual payout of $2.00 per share.
BIXT (Bioxytran, Inc.) — 8368.20% Dividend Yield Analysis
Bioxytran, Inc. (BIXT) is a healthcare stock currently trading at $0.02 with a dividend yield of 8368.20%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (8368.20%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.